Responses of cancer cells with wild-type or tyrosine kinase domain-mutated epidermal growth factor receptor (EGFR) to EGFR-targeted therapy are linked to downregulation of hypoxia-inducible factor-1α
Cited by 61
Related Papers
The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1α and Bcl-2 and Activating the Beclin 1/hVps34 Complex
|Cancer Research|2010|177
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
|British Journal of Cancer|2003|115
Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cells
|Breast Cancer Research|2005|100
Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells
|British Journal of Cancer|2001|65